Enregistrement - Lobbyistes-conseils

Objets

• Commerce international
• Développement économique
• Impôts et finances
• Industrie
• Propriété intellectuelle
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including addressing any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with the Canadian Agency for Drugs and Technologies in Health (CADTH) and/or other pan-Canadian health organizations.
• Federally-funded public drug plans, with respect to reimbursement for drug products for federal plan beneficiaries.
• Innovation, Science and Economic Development Canada regarding the Innovation and Skills Agenda and other government policies and programs related to incentivizing research and development activities in Canada.
• Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board
• The federal role in considering developing and/or funding a national pharmacare program, including engagement with the Advisory Council on the Implementation of National Pharmacare and its Secretariat on issues related to access to medicines and rare disease and orphan drug policies

Politique ou Programme, Proposition législative, Projet de loi ou résolution, Règlement

• Ratification and implementation of the intellectual property-related elements of the United States Mexico Canada Agreement.

Politique ou Programme, Règlement

• Proposed amendments to the Patented Medicines Regulations pre-published in Canada Gazette, Part I on December 2, 2017.
• Regulatory amendments and/or guidelines and/or policies related to the Food and Drugs Act and Health Canada review of drugs for rare diseases.

Techniques de communication

• Communication écrite
• Communication orale

Institutions gouvernementales

• Affaires mondiales Canada (AMC)
• Bureau du Conseil privé (BCP)
• Cabinet du Premier ministre (CPM)
• Chambre des communes
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Innovation, Sciences et Développement économique Canada (ISDE)
• Justice Canada (JC)
• Santé Canada (SC)
• Sénat du Canada

Adresse :
PO Box 81062
Ottawa, ON  K1P 1B1
Canada

Numéro de téléphone : 613-800-8340

Représentant du client

Bob McLay, Chair

Renseignements sur la société mère

iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares / RAREi - The Canadian Forum for Rare Disease Innovators n'est pas une filiale d'une société mère.